Sanofi

Progressing patient-derived material a 'key strategic focus,' says Evotec CEO

Patient-derived induced pluripotent stem cells (iPSC) are reprogrammed into an embryonic-like pluripotent state, enabling researchers to develop various human cells. (Image: iStock/Dr_Microbe)

Evotec and Fraunhofer IME-SP have signed a strategic collaboration to advance Evotec’s patient-derived iPSC platform and subsequent drug discovery projects.

Image: iStock/MiroNovak

DHL consolidates Sanofi's Brazilian distribution network

Image: iStock/ArielMieli

CRO Evotec sees spin-out firm as strategic opportunity

Image: iStock/ArielMieli

Evotec: Strong 2015 down to Sanofi strategic partnership

Sanofi Pasteur is currently at the early research and discovery phase for a Zika vaccine. (Image: iStock/xtrekx)

Sanofi aiming to 'cut years off' vaccine development timelines for Zika says R&D head

President Barack Obama convenes a meeting on the Zika virus, in the Situation Room of the White House, Jan. 26, 2016. (Official White House Photo by Pete Souza)

Pharma, US Gov’t pushing for Zika vaccine

Jobs at risk at Covance's Alnwick site

Covance mulls sacking 130 UK staff at ex Sanofi site; Opens 2nd cGMP pharmacy in US

Architects' plans for the Nottingham, UK facility

$47m innovation facility built in Nottingham, UK

Research consortium looks to identify biomarkers for autism treatments

Research consortium looks to identify biomarkers for autism treatments

FDA offers guidance for running early-phase trials for gene, cell therapies

FDA offers guidance for running early-phase trials for gene, cell therapies

More Sanofi